Treace Medical Company Top Insiders

TMCI Stock  USD 5.65  0.14  2.42%   
Under 75 percent of all Treace Medical's insiders are aggressively buying. The analysis of insiders' sentiment of trading Treace Medical Concepts stock suggests that a large number of insiders are very bullish at this time. Treace Medical employs about 477 people. The company is managed by 18 executives with a total tenure of roughly 1113 years, averaging almost 61.0 years of service per executive, having 26.5 employees per reported executive.

Insider Sentiment 75

 Mostly Buying

 
Selling
 
Buying

Latest Trades

2025-03-17Sean F ScanlanDisposed 50000 @ 7.97View
2024-09-16John T TreaceAcquired 50000 @ 5.31View
2024-08-15James T TreaceAcquired 84000 @ 5.96View
2024-08-14John T TreaceAcquired 85000 @ 6View
Monitoring Treace Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Treace Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.1456) % which means that it has lost $0.1456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4573) %, meaning that it created substantial loss on money invested by shareholders. Treace Medical's management efficiency ratios could be used to measure how well Treace Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.3. The current Return On Capital Employed is estimated to decrease to -0.32. As of now, Treace Medical's Asset Turnover is decreasing as compared to previous years.
The current Common Stock Shares Outstanding is estimated to decrease to about 61.4 M. The Treace Medical's current Net Loss is estimated to increase to about (36.6 M)

Treace Medical Workforce Comparison

Treace Medical Concepts is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 4,902. Treace Medical holds roughly 477 in number of employees claiming about 10% of equities under Health Care industry.

Treace Medical Profit Margins

The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.3) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.3.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.640.8037
Significantly Down
Slightly volatile

Treace Medical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Treace Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Treace Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Treace Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-06-01
8.0
8
1
 175,194 
 1,894 
2025-03-01
0.4118
7
17
 865,625 
 152,605 
2024-12-01
3.0
3
1
 378,550 
 3,787 
2024-09-01
9.0
9
1
 970,900 
 33,750 
2024-03-01
0.9
9
10
 782,600 
 18,386 
2023-06-01
0.9333
14
15
 85,653 
 1,324,785 
2023-03-01
0.2778
15
54
 755,453 
 1,124,418 
2022-12-01
0.3333
15
45
 188,242 
 778,417 
2022-09-01
0.4167
5
12
 34,000 
 165,497 
2022-06-01
1.0
7
7
 49,735 
 181,911 
2022-03-01
0.6296
17
27
 325,450 
 1,025,002 
2021-12-01
0.1071
6
56
 1,181,507 
 3,493,756 
2021-09-01
1.5
3
2
 693,816 
 560,000 
2021-06-01
0.7
35
50
 4,226,159 
 13,423,217 

Treace Medical Notable Stakeholders

A Treace Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Treace Medical often face trade-offs trying to please all of them. Treace Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Treace Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John TreaceChairman FounderProfile
Shana ZinkSenior ReimbursementProfile
Julie DeweyChief OfficerProfile
Brad BarrSenior SalesProfile
Scot JDChief SecretaryProfile
Thomas TimbieIndependent DirectorProfile
Sean ScanlanChief OfficerProfile
Guy GuglielminoChief OfficerProfile
Nathan MinnichSenior MarketingProfile
Scot ElderChief SecretaryProfile
Rachel OsbeckSenior AffairsProfile
Mark CPAChief OfficerProfile
Taylor EricksonChief OfficerProfile
Aaron BeruttiSenior SalesProfile
Jaime FriasChief OfficerProfile
Gaetano GuglielminoChief OfficerProfile
Daniel OwensChief OfficerProfile
Terry LubbenSenior OperationsProfile

About Treace Medical Management Performance

The success or failure of an entity such as Treace Medical Concepts often depends on how effective the management is. Treace Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Treace management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Treace management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.28)(0.30)
Return On Capital Employed(0.31)(0.32)
Return On Assets(0.26)(0.27)
Return On Equity(0.49)(0.52)

Treace Medical Workforce Analysis

Traditionally, organizations such as Treace Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Treace Medical within its industry.

Treace Medical Manpower Efficiency

Return on Treace Medical Manpower

Revenue Per Employee438.9K
Revenue Per Executive11.6M
Net Loss Per Employee116.9K
Net Loss Per Executive3.1M
Working Capital Per Employee265.2K
Working Capital Per Executive7M

Complementary Tools for Treace Stock analysis

When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets